Ticker LaunchLondon · AIM · IPO · POLB
Poolbeg Pharma plc
Poolbeg Pharma plc (POLB) was admitted to AIM on Jul 19, 2021, raising £25M at 10p per share. Its market capitalization at admission was about £50M. finnCap Ltd acted as nominated adviser, with Arden Partners PLC and J&E Davy as broker.
Poolbeg Pharma is a clinical-stage infectious disease pharmaceutical company with a capital-light clinical model, developing POLB 001 as a treatment for severe influenza.
- Type
- IPO
- Market
- AIM
- Ticker (TIDM)
- POLB
- Admitted
- Jul 19, 2021
- Offer price
- 10p
- Raised
- £25M
- Market cap at admission
- £50M
- Nominated adviser
- finnCap Ltd
- Brokers
- finnCap Ltd, Arden Partners PLC and J&E Davy
- Sector
- Biotech & pharma
- Country
- United Kingdom
More on this listing for subscribers
- Intention-to-float date
- New money versus sale shares
- ISIN
- Source announcements
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Sources
From company announcements filed with the FCA's National Storage Mechanism. Subscribers see the list of announcements for each listing.
Other London listings around the same time
- Lords Group Trading PlcAIM · Jul 20, 2021
- Revolution Beauty Group plcAIM · Jul 19, 2021
- Sivota PlcMain Market · Jul 19, 2021
- Forward Partners Group PlcAIM · Jul 19, 2021
- Acceler8 Ventures PlcMain Market · Jul 19, 2021
- Bradda Head Holdings LimitedAIM · Jul 19, 2021